SAB Biotherapeutics, Inc.
SABS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001833214
No open-market purchases or sales by SAB Biotherapeutics, Inc. insiders were filed in the last 90 days; 87 institutions reported holding it in 13F filings for Q2 2026, worth $266.8M in total; no superinvestor holds it.
Other share classesSABSW
13F holders, Q1 2022
Institutional positions in SAB Biotherapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 27
- −7 vs. Q4 2021
- Shares held
- 1.79M
- −1.31M (−42.2%) vs. Q4 2021
- Total value
- $6.71M
- −$18.7M (−73.6%) vs. Q4 2021
- New holders
- 2
- 14 more added
- Sold out
- 9
- 6 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SABS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 87 | $266.8M |
| Q1 2026 | 76 | $265.0M |
| Q4 2025 | 48 | $135.9M |
| Q3 2025 | 34 | $56.3M |
| Q2 2025 | 25 | $3.37M |
| Q1 2025 | 26 | $2.99M |
| Q4 2024 | 25 | $10.1M |
| Q3 2024 | 25 | $8.48M |
| Q2 2024 | 22 | $9.69M |
| Q1 2024 | 24 | $15.2M |
| Q4 2023 | 42 | $24.5M |
| Q3 2023 | 34 | $2.41M |
| Q2 2023 | 38 | $3.28M |
| Q1 2023 | 39 | $1.71M |
| Q4 2022 | 38 | $2.42M |
| Q3 2022 | 40 | $2.32M |
| Q2 2022 | 37 | $4.45M |
| Q1 2022 | 27 | $6.71M |
| Q4 2021 | 34 | $25.4M |
| Q3 2021 | 1 | $605.0K |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding SAB Biotherapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 721,151 | $2.71M | 0.00% | +38,179+5.6% | Added |
| Geode Capital Management, LLC | 301,110 | $1.13M | 0.00% | +7,704+2.6% | Added |
| Shaolin Capital Management LLC | 275,000 | $1.03M | 0.03% | +35,250+14.7% | Added |
| Institutional & Family Asset Management, LLC | 78,115 | $294.0K | 0.05% | 00.0% | Unchanged |
| BlackRock Inc. | 72,518 | $273.0K | 0.00% | +910+1.3% | Added |
| Creative Planning | 46,528 | $175.0K | 0.00% | +46,528 | New |
| Alps Advisors Inc | 45,083 | $170.0K | 0.00% | −5,223−10.4% | Reduced |
| Northern Trust Corp | 44,476 | $167.0K | 0.00% | 00.0% | Unchanged |
| Veritable, L.P. | 43,551 | $164.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 42,341 | $159.0K | 0.00% | +30,041+244.2% | Added |
| Morgan Stanley | 24,964 | $95.0K | 0.00% | −7,276−22.6% | Reduced |
| Qube Research & Technologies Ltd | 24,179 | $91.0K | 0.00% | +7,362+43.8% | Added |
| Goldman Sachs Group Inc | 15,494 | $58.0K | 0.00% | +1,005+6.9% | Added |
| ETF Managers Group, LLC | 13,187 | $34.0K | 0.00% | −15−0.1% | Reduced |
| Citigroup Inc | 7,019 | $26.0K | 0.00% | +5,732+445.4% | Added |
| Wolverine Asset Management LLC | 6,426 | $24.0K | 0.00% | −176−2.7% | Reduced |
| Spectrum Management Group, LLC | 5,030 | $19.0K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 5,000 | $19.0K | 0.00% | +1,168+30.5% | Added |
| Royal Bank of Canada | 4,820 | $18.0K | 0.00% | +2,820+141.0% | Added |
| Penserra Capital Management LLC | 3,724 | $14.0K | 0.00% | +238+6.8% | Added |
| Bank of America Corp | 2,779 | $10.0K | 0.00% | +605+27.8% | Added |
| Tower Research Capital LLC (TRC) | 1,731 | $7.00K | 0.00% | +166+10.6% | Added |
| UBS Group AG | 1,407 | $6.00K | 0.00% | −4,546−76.4% | Reduced |
| Advisor Group Holdings, Inc. | 1,330 | $5.00K | 0.00% | −683−33.9% | Reduced |
| Rockefeller Capital Management L.P. | 1,100 | $4.00K | 0.00% | +400+57.1% | Added |
| Money Concepts Capital Corp | 250 | $1.00K | 0.00% | +250 | New |
| Daiwa Securities Group Inc. | 127 | $0 | 0.00% | 00.0% | Unchanged |
| First PREMIER Bank | 0 | $0 | 0.00% | −832,555−100.0% | Sold out |
| Radcliffe Capital Management, L.P. | 0 | $0 | 0.00% | −546,658−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −24,230−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −15,379−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −15,117−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −12,899−100.0% | Sold out |
| Nadler Financial Group, Inc. | 0 | $0 | 0.00% | −11,000−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −498−100.0% | Sold out |